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Abstract
Background: Chlamydia trachomatis infections are the most prevalent sexually transmitted bacterial infections in
the world. There is scarce data available referring to the distribution of C. trachomatis genotypes in Argentina. The
aim of this study was to identify the genotypes of C. trachomatis circulating in the metropolitan area of Buenos
Aires (Argentina) associated with ophthalmia neonatorum and genital infections.
Findings: From 2001 to 2006, 199 positive samples for C. trachomatis infection from symptomatic adult patients
and neonates with ophthalmia neonatorum from two public hospitals were studied. C. trachomatis genotypes were
determined by PCR-RFLP of an ompA fragment.
Genotype E was the most prevalent regardless of the sample origin (46.3% 57/123 in adults and 72.4% 55/76 in
neonates), followed by genotype D (19.5% 24/123) and F (14.6% 18/123) in adults, and G (9.2% 7/76) and D (7.9%
6/76) in neonates. We detected a significantly higher frequency of genotype E (p < 0.001, OR = 3.03
(1.57<OR<5.90)) in ophthalmia neonatorum than in genital specimens. Genotype D was associated with genital
localization (p < 0.05, OR = 2.83 (1.03<OR<8.18)).
Conclusion: We found a particularly increased frequency of C. trachomatis genotype E in neonatal conjunctivitis,
which may indicate an epidemiological association between this genotype and the newborn population. The
present study also contributed to increase the knowledge on genotype distribution of Chlamydia trachomatis in
symptomatic adult patients in Buenos Aires, Argentina, in which genotypes E, D and F were the predominant ones.
Introduction
Chlamydia trachomatis infections are the most preva-
lent sexually transmitted bacterial infections in the
world. The World Health Organization estimated that
90 million new cases of chlamydial infections occurred
globally in 1999 [1].
T h ep r e v a l e n c eo fC. trachomatis lower tract infec-
tions varies from 2-25% according to the studied popu-
lation, and is highest among adolescents [2]. Chlamydial
infections are often asymptomatic (70-80% of women
and up to 50% of men) and may therefore remain
untreated. In women, an untreated infection can lead to
pelvic inflammatory disease (PID), chronic pelvic pain,
and, at a later stage, to ectopic pregnancy and tubal fac-
tor infertility [3].
Infants exposed to C. trachomatis at birth are at
increased risk of developing eye and lung infections
such as conjunctivitis and pneumonia and the estimated
incidence of such infections in those newborn babies is
15% and 7% respectively [4-6]. Prevalence of neonatal
conjunctivitis due to C. trachomatis has been reported
to be about 8%, but it varies widely depending on preva-
lence values in their mothers [7-9].
C. trachomatis serotyping is based on immunogenic
epitope analysis of the major outer membrane protein
(MOMP), and it differentiates 18 serovars. Among
these, serovars A to C are associated with trachoma, ser-
ovars D to K are common urogenital and ocular
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dial neonatal conjunctivitis worldwide, and serovars L1
to L3 are associated with lymphogranuloma venereum.
Genotyping techniques are based on the analysis of the
sequence changes in the single copy gene ompAt h a t
encodes MOMP. Genotype classification correlates with
the serovar classification previously mentioned [10], but
even though this classification is practical and accepted
among researchers, does not allow establishing relation-
ships between isolates. The application of new typing
schemes based on sequencing a number of C. trachoma-
tis variable genes, like MLST (Multi Locus Sequence
Typing), will help to have a better understanding on the
epidemiology and transmission of C. trachomatis infec-
tions [11].
C. trachomatis infection has not been largely studied
in neonates regarding ophthalmia neonatorum and
pneumonia [12-15] and data available on C. trachomatis
serovar distribution associated to neonatal conjunctivitis
is scarce. Datta et al. [16] studied C. trachomatis sero-
vars in ophthalmia neonatorum in a trachoma endemic
area, and reported that none of the identified serovars
from infants with neonatal conjunctivitis belonged to
the classic trachoma serovars. We have recently
reported that serovar E was the most frequently
detected serovar (71.0%) in a small population of neo-
nates with neonatal conjunctivitis in Buenos Aires,
Argentina [17].
The biological basis of the association between a clus-
ter or a defined genotype of C. trachomatis and a parti-
cular disease is not yet well understood [18,19] and
might be the result of many factors.
The aim of this study was to investigate the distribu-
tion of C. trachomatis genotypes among a population of
patients showing symptoms of ophthalmia neonatorum
and genital disease in the metropolitan area of Buenos
Aires (Argentina).
Methods
Study Population
Samples included in this study were obtained from
patients demanding diagnosis at the university hospital
(Hospital de Clínicas “José de San Martín”, University of
Buenos Aires hospital, HJSM), located in downtown
Buenos Aires, and at the national hospital (Hospital
Nacional Prof Dr. A. Posadas, HNAP) located in the
suburbs of Buenos Aires. Positive samples for C. tracho-
matis infection collected between January 2001 and
December 2006 both from newborn babies (aged under
30 days) with ophthalmia neonatorum a n df r o ma d u l t s
with genital symptoms were studied.
Patients were managed under standard approved hos-
pital procedures. The population attending both hospi-
tals belonged to lower and lower-middle classes and
attended general practitioner’s office. Neither STD clinic
patients nor mother-child pairs were included in this
study.
All neonates presented clinical signs of conjunctivitis.
The most frequent symptoms described by adult
patients from both hospitals included urethral or vaginal
discharge, dyspareunia, dysuria, lower abdominal pain,
and genital burning or itching sensation.
Sample collection and detection of C. trachomatis
Ocular specimens from neonates and endocervical and
urethral specimens from adult patients were collected
using sterile Dacron tipped swabs.
All the samples obtained at the university hospital
were placed in 2-sucrose phosphate (2SP) solution and
were then analysed by ompA PCR and cultured in LLC-
MK2 cells.
Specimens collected at the HNAP were analysed with
two commercial ELISA tests. Between January 2001 and
December 2004 Chlamydiazyme (Abbott Laboratories,
Chicago IL) was used, and miniVIDAS (bioMerieux,
Marcy l’ Etoile, France) was used between January 2005
and December 2006. Antigen detection was performed
according to the manufacturer’s instructions. Fractions
of ELISA-positive samples obtained in the period from
2001 to 2004 and from all samples obtained in 2005 and
2006 were frozen at -20°C and then transported in dry
ice from the national hospital to the HJSM for further
analysis by ompA PCR.
Cell culture
Confluent cultures of LLC-MK2 cells (kindly provided
by Sezione di Microbiologia DMCSS, Universitá degli
Studi di Bologna, Bologna, Italy), grown at 37°C and 5%
CO2 in culture media (minimum essential medium
(MEM, Gibco), supplemented with 10% foetal calf
serum (FCS, PAA Lab. GmbH, Austria), 0.1 mM non-
essential amino acids (Gibco), 50 mg/L gentamicin, and
2 mM glutamine) were inoculated in duplicate with 500
μl of the 2SP sample suspension, and centrifuged at 700
g for 1 hour at 30°C. After a 72-hour incubation, one of
each duplicate was methanol-fixed and stained with a
genus-specific fluorescein-conjugated monoclonal anti-
body (Merifluor Chlamydia, Meridian Diagnostics Inc.
Cincinnati, Ohio), following the manufacturer’si n s t r u c -
tions [20].
OmpA PCR
The ompAg e n eo fC. trachomatis was amplified using
the methodology describe by Lan et al. [21]. Briefly, an
approximately 1 kb fragment of the ompA gene was
amplified using primers SERO1A (5’-ATG AAA AAA
CTC TTG AAA TCG G-3’)a n dS E R O 2 A ,( 5 ’-TTT
CTA GAT CTT CAT TCT TGT T-3’). The reaction
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mM MgCl2, 0.05 mM of each deoxynucleotide tripho-
sphate, 0.32 μM of each primer, 2 U of Taq DNA poly-
merase (Invitrogen Corporation, Brazil), and 10 μlo f
clinical specimen.
Cycling conditions began with an initial 7 min dena-
turation step at 94°C, followed by 40 cycles of denatura-
tion at 95°C for 1 min, annealing at 45°C for 3 min, and
extension at 72°C for 3 min. An additional 7-min exten-
sion at 72°C was performed at the end of the 40 cycles.
DNA of C. trachomatis L2/BU/434, (kindly provided
by Sezione di Microbiologia DMCSS, Università degli
Studi di Bologna, Bologna, Italy) and mock-infected cells
were included as positive and negative controls
respectively.
Then, 1 μl of the first-round PCR product was used
for the semi-nested PCR, which was performed with the
same reagents and conditions except for the primers,
which were SERO2A, and one nested primer: PCTM3,
(PCTM3: 5’-TCC TTG CAA GCT CTG CCT GTG
GGG AAT CCT-3’). The PCR products of the second
round were checked for correctness on ethidium-bro-
mide stained 1.5% agarose gels. Positive results were
routinely subjected to RFLP analysis, to determine the
genotype and verify the absence of contamination with
positive controls or cross-sample carry-over.
This semi-nested PCR was able to detect 1 to 10
inclusion-forming units in our laboratory conditions.
RFLP genotyping
RFLP analysis of PCR-positive samples was carried out
as described by Sayada et al. [22], using the semi-nested
PCR product of approximately 1-Kbp. Briefly, 10 μlo f
the nested PCR product was digested with 2.5 U of AluI
(Promega, Madison, WI). Depending on the AluIp a t -
tern, amplified samples were analyzed, if necessary, with
HinfI, DdeIo rEcoRI (Promega, Madison, WI), according
to the manufacturer’s instructions.
Genotypes were identified by their restriction patterns
on ethidium bromide stained 12% polyacrylamide gel
electrophoresis.
Genotypes identified by RFLP from samples obtained
between January 2005 and December 2006 were sent to
ompA sequencing for verification, using the procedure
of Jonsdottir et al [23].
Statistical analysis
Epi Info version 2000 software (Center for Disease Con-
trol and Prevention, Atlanta, GA) was used to assess dif-
ferences by application of the chi-square and exact
binomial methods. Values of p ≤ 0.05 were considered
statistically significant.
Results
A total of 199 positive samples for C. trachomatis were
collected from newborn babies and symptomatic adult
patients attending the HJSM and HNAP between 2001
and 2006 (76 conjunctival sawbs, 42 male urethral
scrapes and 81 cervical scrapes).
Over the 76 ompA positive samples detected among
neonates, the genotypes identified and their distribution
order were as follows: E (72.4%), G (9.2%), D (7.9%), F
(5.3%), K (2.6%), H (1.3%) and I (1.3%).
Among the 81 positive endocervical swabs, the follow-
i n gg e n o t y p e sw e r ei d e n t i f i e d :E( 4 6 . 9 % ) ,D( 2 1 . 0 % ) ,F
(16.1%), I (4.9%), K (4.9%), G (2.5%), Ja (2.5%) and H
(1.2%). There was one mixed infection detected in an
endocervical sample containing genotypes E and F.
The genotype distribution among male urethral sam-
ples was: E (45.2%), D (16.8%), F (11.9%), G (9.5%), I
(9.5%), and K (7.1%).
Neither genotypes A, B or C, nor L1 to L3 were
detected in this study. The genotype distribution found
in the two categories of examined samples, i.e. genital
and ocular is given in Figure 1.
No significant differences on genotype distribution
were found, neither between the two temporary sub-
groups from HNAP nor between the two hospitals.
There were no significant differences between genders
among genital genotypes (data not shown).
Altogether, the most frequently detected genotype was
E, regardless of the sample’s origin, but its frequency
turned out to be significantly higher in neonatal ocular
samples (p = 0.00056, OR = 3.03 (1.57<OR<5.90)) than
in genital samples. Genotype D was negatively associated
with ocular localization (p < 0.05, OR = 0.35
(0.11<OR<0.95)). The association of genotypes with ocu-
lar or genital disease are summarized respectively in
Table 1.
Discussion
In the present study we investigated the distribution of
genotypes of C. trachomatis, which were obtained from
newborn babies with ophthalmia neonatorum and symp-
tomatic adult patients in a six-year period in two hospi-
tals in Buenos Aires, Argentina.
Among symptomatic adults, genotypes E (45.2% in
men and 46.9% in women), D (16.7% and 21.0%, respec-
tively), and F (11.9% and 16.1%, respectively) were the
most common ones, while H and Ja were rare. We
found one mixed infection (0.5%) during this study, and
this suggests a low prevalence of mixed infections in our
population which is in agreement with the findings of
Jonsdottir et al. [23], who detected 1% of mixed infec-
tions. The genotype distribution that we report in symp-
tomatic adult patients was similar to previously reported
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researchers where they found that genotype E was the
most prevalent followed by F and D [25,26]. A limitation
of the present study is that most of the samples were
typed by RFLP and not ompA sequencing, so no distinc-
tion between D, Da and D variants was done. Although
genotype D in our study is more prevalent than F, this
could be the result from the fact that D also involves Da
and D variant strains.
The high percentage of genotype E (72.4%) among
neonatal ocular samples is in agreement with our pre-
vious report, where we found a predominance of this
genotype in samples from newborn babies with neonatal
conjunctivitis [17]. Even though these findings could be
due to the genital predominance of genotype E, this fact
might not be the only explanation of the higher detec-
tion rate of this genotype in neonatal conjunctivitis.
Figure 1 Genotype distribution among 42 male urogenital samples, 81 female urogenital samples and 76 neonatal conjunctival
samples.
Table 1 C. trachomatis genotype distribution according to sample origin.
Type of sample
Genotype detected Neonatal conjunctival
a
n (%)
Adult urogenital
b
n (%)
P value
B Complex
D 6 (7.9) 24 (19.5) 0.043
E 55 (72.4) 57 (46.3) 0.00056
Intermediate Group
F 4 (5.3) 18 (14.6) 0.069
G 7 (9.2) 6 (4.9) 0.36
C Complex
H 1 (1.3) 1 (0.8) 0.69
I 1 (1.3) 8 (6.5) 0.17
Ja 0 2 (1.6) 0.53
K 2 (2.6) 7 (5.7) 0.51
a76 neonatal conjunctival swabs.
b42 male urethral swabs, and 81 endocervical swabs. The distribution by gender is given in Figure 1.
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zation of an ELISA assay as the only diagnostic test
used at the HNAP from 2001 to 2004, which could have
resulted in false negative findings in a substantial por-
tion of the samples studied. However, even when all
samples from the HJSM were studied both by culture
and a sensitive PCR, we did not find significant differ-
ences on the genotype distribution among adults
between both hospitals. Moreover, all samples from the
HNAP collected from 2005 to 2006 were tested by
ELISA and ompA PCR, and we did not find significant
differences in genotype distribution compared with the
one obtained for the 2001-2004 period. Hence, Gomes
et al. [27] have shown that there is no association
between genotype and chlamydial load at the infection
site in genital specimens, which also supports the notion
that the sensitivity of ELISA did not biased the genotype
distribution. Another possible limitation of this study is
that we only studied adult symptomatic patients and
newborn babies with clinical signs of conjunctivitis,
which could have biased our results. However other
study findings in asymptomatic population have found
frequencies of genotype E similar to ours [25].
We hypothesize that some kind of selective pressure
could explain the high frequency of genotype E in neo-
natal conjunctivitis. On the one hand, it may be reflect-
ing the difference in the immune status between
neonates and adults. This is supported by the fact that
there is a difference in the distribution of genital geno-
types correlated with the patients’ age and with a predo-
minance of genotype E in adolescents [26], whereas
there is an equal correlation in the distribution of C.
trachomatis genotypes between urogenital and adult
conjunctivitis eye samples [28,29]. On the other hand,
C. trachomatis genotype E could have an enhanced cap-
ability of infecting the conjunctival mucosa of neonates
as compared to other genotypes or a differential
mother-child transmission dynamic over other geno-
types. This idea is supported by the negative association
of genotype D with ophthalmia neonatorum, given that
this serovar is the second most frequent one in our
adult female population but the third one in neonatal
ocular samples. In order to confirm this negative asso-
ciation, the distinction between D, Da and D variants
would be necessary.
It is possible that the higher frequency of genotype E
could be due to distinctive characteristic of some strains
of this genotype. The analysis of portions of the C. tra-
chomatis genome which are rich in SNPs (single nucleo-
tide polymorphisms) [30], as well as the application of
new typing schemes based on sequencing a number of
C. trachomatis variable genes (MLST) [11] may provide
a better understanding of this phenomenon. Further-
more, an assessment of specific immunity in different
age groups and in vitro studies of infectivity and cito-
toxicity of different genotypes in conjunctival cell lines
may also help to clarify our hypothesis.
Conclusions
This study confirmed an increased frequency of geno-
type E in neonatal ocular samples. The present study
also contributed to increase the knowledge on genotype
distribution of C. trachomatis in adult symptomatic
patients that attended two public hospitals in Buenos
Aires city, Argentina, in which genotypes E, D and F
were the predominant ones. This genotype distribution
constitutes one of the few reports of this kind in Latin
America.
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